Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amgen’s Nplate Has First Mandatory Patient Registration Under REMS

Sep 22 2008

• By Jamie Hammon

Related Content

GSK’s Promacta Gets ODAC Nod Despite Concerns Of Off-Label, Long-Term Use

Jun 02 2008

With Promise Of Post-Market Safety Studies, Panel Backs Amgen’s Nplate

Mar 17 2008

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window